Exhibit 99.1
 
External Investor Relations Contact:
Kirin Smith
PCG Advisory Group
(646) 863-6519
ksmith@pcgadvisory.com
 
Investor Relations/
Media Contact:
Todd Waltz
(408) 213-0940
investors@aemetis.com
 
Aemetis, Inc. Reports Second Quarter 2020 Financial Results
Earnings of $0.10 per Share; Net Income of $2.2 Million; Adjusted EBITDA of $11.2 Million Driven by Sales of High Grade Alcohol for Hand Sanitizer
 
CUPERTINO, Calif. – August 13, 2020 -
Aemetis, Inc. (NASDAQ: AMTX), an advanced renewable fuels and biochemicals company, today announced its financial results for the three and six months ended June 30, 2020.
 
Aemetis’ second quarter of 2020 included significant announcements and financial achievements related principally to sales of high-grade alcohol, including:
 
Gross Profit of $14.1 million
Net Income of $2.2 million
Adjusted EBITDA of $11.2 million
Announced plans to produce US Pharmacopeia (USP) grade alcohol
 
“As a result of the global COVID-19 pandemic, demand for high grade alcohol for sanitizer production and shipments of alcohol to bulk sanitizer alcohol customers increased dramatically in the second quarter,” said Eric McAfee, Chairman and CEO of Aemetis. “In the final weeks of Q1, we adopted a variety of process improvements and plant upgrades to produce large volumes of high grade alcohol for hand sanitizer. Due to pandemic-related demand as well as what we expect will be longer-term behavioral changes by consumers to reduce the spread of viruses, we anticipate continued market growth for hand sanitizers, personal care and cleaning markets, which contain high grade alcohol,” added McAfee.
 
“As the largest capacity high grade alcohol producer in the Western US,” McAfee stated, “Aemetis is implementing systems and equipment that we believe will enable us to produce USP grade alcohol in Q1 2021. We are also developing expanded marketing channels in the US, Canada and other countries for the sale of bulk sanitizer alcohol, bulk blended liquid and gel sanitizer, along with private label and Aemetis-branded and packaged sanitizer products.”
 
Today, Aemetis will host an earnings review call at 11:00 a.m. Pacific time (PT).
 
Live Participant Dial In (Toll Free): +1-844-602-0380
Live Participant Dial In (International): +1-862-298-0970
Webcast URL:  https://www.webcaster4.com/Webcast/Page/2211/36421
 
For details on the call, please visit http://www.aemetis.com/investors/conference-calls/
 
 
1
 
 
Financial Results for the Three Months Ended June 30, 2020
 
Revenues were $47.8 million for the second quarter of 2020 compared to $50.6 million for the second quarter of 2019, driven by the entry into the high-grade alcohol market, but were slightly offset by the delay in the India Government Oil Marketing Company biodiesel bidding process.
 
Gross profit for the second quarter of 2020 rose to $14.1 million, compared to a gross profit of $3.3 million during the second quarter of 2019. North America segment accounted for $13.9 million of the reported, consolidated gross profit.
 
Selling, general and administrative expenses were $4.0 million during the second quarter of 2020, compared to $3.9 million during the second quarter of 2019.
 
Operating income increased to $10.0 million for the second quarter of 2020, compared to an operating loss of $0.8 million for the second quarter of 2019.
 
Interest expense during the second quarter of 2020 was $6.2 million, excluding accretion in connection with Series A preferred units in the Aemetis Biogas LLC subsidiary, compared to $6.6 million during the second quarter of 2019. The Aemetis Biogas subsidiary recognized $1.4 million of accretion in connection with preference payments on its preferred stock.
 
Net income was $2.2 million for the second quarter of 2020, compared to a net loss of $13.9 million for the second quarter of 2019.
 
Adjusted EBITDA increased to $11.2 million for the three months ended June 30, 2020.
 
Cash at the end of the second quarter of 2020 increased to $3.4 million, compared to $0.6 million at the end of 2019.
 
Financial Results for the Six Months Ended June 30, 2020
 
Revenues were $87.3 million for the first half of 2020, compared to $92.5 million for the first half of 2019.
 
Selling, general and administrative expenses were $8.0 million during the first half of 2020, compared to $8.2 million during the first half of 2019.
 
Operating income increased to $5.5 million for the first half of 2020, compared to an operating loss of $5.4 million for the first half of 2019.
 
Interest expense was $13.1 million during the first half of 2020, excluding accretion of Series A preferred units in the Aemetis Biogas LLC subsidiary, compared to interest expense of $12.8 million during the first half of 2019. Additionally, the Aemetis Biogas subsidiary recognized $2.3 of accretion in connection with preference payments on its preferred stock.
 
Net loss for the first half of 2020 was $9.9 million, compared to a net loss of $24.6 million in 2019, when the Company recorded a one-time charge for loss contingency on litigation. The 2020 margin improvement was due in large part to selling high-grade alcohol into the hand sanitizer market.
 
Adjusted EBITDA was $8.2 million for the six months ended June 30, 2020.
 
 
2
 
 
About Aemetis
 
Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced biorefineries. Founded in 2006, Aemetis owns and operates a 65 million gallon per year ethanol production facility in California’s Central Valley near Modesto. Aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. Aemetis is building a biogas anaerobic digester network and pipeline to convert dairy animal waste gas to Renewable Natural Gas (RNG), and is developing a plant to convert waste orchard wood into high grade cellulosic alcohol. Aemetis holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.
 
NON-GAAP FINANCIAL INFORMATION
 
We have provided non-GAAP measures as a supplement to financial results based on GAAP. A reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is included in the accompanying supplemental data. Adjusted EBITDA is defined as net income/(loss) plus (to the extent deducted in calculating such net income) interest expense, loss on extinguishment, income tax expense, intangible and other amortization expense, accretion expense, depreciation expense, loss contingency on litigation and share-based compensation expense.
 
Adjusted EBITDA is not calculated in accordance with GAAP and should not be considered as an alternative to net income/(loss), operating income or any other performance measures derived in accordance with GAAP or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA is presented solely as a supplemental disclosure because management believes that it is a useful performance measure that is widely used within the industry in which we operate. In addition, management uses Adjusted EBITDA for reviewing financial results and for budgeting and planning purposes. EBITDA measures are not calculated in the same manner by all companies and, accordingly, may not be an appropriate measure for comparison between companies.
 
Safe Harbor Statement
 
This news release contains forward-looking statements, including statements regarding our assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts. Forward-looking statements in this news release include, without limitation, expectations for growth in India and development of our cellulosic ethanol business in North America.  Words or phrases such as “anticipates,” “may,” “will,” “should,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “showing signs,” “targets,” “view,” “will likely result,” “will continue” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current assumptions and predictions and are subject to numerous risks and uncertainties. Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without limitation, competition in the ethanol, biodiesel and other industries in which we operate, commodity market risks including those that may result from current weather conditions, financial market risks, customer adoption, counter-party risks, risks associated with changes to federal policy or regulation, demand for high grade alcohol and related products, including hand sanitizers, and other risks detailed in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2019, our Quarterly Report on Form 10-Q for the quarters ended March 31, 2020 and June 30, 2020 and in our subsequent filings with the SEC. We are not obligated, and do not intend, to update any of these forward-looking statements at any time unless an update is required by applicable securities laws.
 
(Tables follow)
 
 
3
 
 
AEMETIS, INC.
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(unaudited, in thousands except per share data)
 
 
 
Three months ended
 
 
Six months ended 
 
 
 
June 30,
 
 
June 30,
 
 
 
2020
 
 
2019
 
 
2020
 
 
2019
 
Revenues
 $47,824 
 $50,619 
 $87,304 
 $92,507 
Cost of goods sold
  33,765 
  47,346 
  73,678 
  89,585 
Gross profit
  14,059 
  3,273 
  13,626 
  2,922 
 
    
    
    
    
Research and development expense
  21 
  90 
  138 
  123 
Selling, general and admin. expense
  4,049 
  3,945 
  7,985 
  8,186 
Operating income (loss)
  9,989 
  (762)
  5,503 
  (5,387)
 
    
    
    
    
Interest expense
    
    
    
    
Interest rate expense
  5,574 
  5,190 
  11,160 
  10,176 
Amortization expense
  614 
  1,396 
  1,904 
  2,619 
Accretion of Series A preferred units
  1,362 
  471 
  2,322 
  920 
Loss contingency on litigation
  -- 
  6,200 
  -- 
  6,200 
Other (income) expense
  303 
  (89)
  240 
  (712)
Income (loss) before income taxes
  2,136 
  (13,930)
  (10,123)
  (24,590)
 
    
    
    
    
Income tax expense (benefit)
  (56)
  -- 
  (263)
  7 
 
    
    
    
    
Net income (loss)
 $2,192 
 $(13,930)
 $(9,860)
 $(24,597)
 
    
    
    
    
Non-controlling interest
  -- 
  (994)
  -- 
  (1,932)
Net income (loss) attributable to Aemetis, Inc.
  2,192 
  (12,936)
  (9,860)
  (22,665)
 
    
    
    
    
Net income (loss) per common share
    
    
    
    
Basic
 $0.11 
 $(0.63)
 $(0.48)
 $(1.11)
Diluted
 $0.10 
 $(0.63)
 $(0.48)
 $(1.11)
 
    
    
    
    
Weighted average shares outstanding
    
    
    
    
Basic
  20,683 
  20,375 
  20,668 
  20,371 
Diluted
  21,153 
  20,375 
  20,668 
  20,371 
 
 
4
 
 
AEMETIS, INC.
CONSOLIDATED CONDENSED BALANCE SHEETS
(in thousands)
 
 
 
June 30,
2020
(Unaudited)
 
 
December 31,
2019
 
Assets
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
Cash and cash equivalents
 $3,410 
 $656 
Accounts receivable
  5,202 
  2,036 
Inventories
  7,290 
  6,518 
Prepaid and other current assets
  2,034 
  3,366 
Total current assets
  17,936 
  12,576 
 
    
    
  Property, plant and equipment, net
  98,525 
  84,226 
Right-of-use and other assets
  5,697 
  3,094 
Total assets
 $122,158 
 $99,896 
 
    
    
Liabilities and stockholders' deficit
    
    
Current liabilities:
    
    
Accounts payable
 $16,367 
 $15,968 
Current portion of long term debt
  7,569 
  5,792 
Short term borrowings
  16,096 
  16,948 
Mandatorily redeemable Series B stock
  3,200 
  3,149 
Accrued property taxes and other current liabilities
  16,766 
  15,962 
Total current liabilities
  59,998 
  57,819 
 
    
    
Total long term liabilities
  226,359 
  196,449 
 
    
    
Stockholders' deficit:
    
    
    Series B convertible preferred stock
  1 
  1 
    Common stock
  21 
  21 
    Additional paid-in capital
  87,580 
  86,852 
    Accumulated deficit
  (247,281)
  (237,421)
    Accumulated other comprehensive loss
  (4,520)
  (3,825)
Total stockholders’ deficit
  (164,199)
  (154,372)
Total liabilities and stockholders' deficit
 $122,158 
 $99,896 
 
 
5
 
 
RECONCILIATION OF ADJUSTED EBITDA TO NET LOSS
(unaudited, in thousands)
 
 
 
Three Months Ended June 30,
 
 
Six Months Ended June 30,
 
 
 
2020
 
 
2019
 
 
2020
 
 
2019
 
Net income (loss) attributable to Aemetis, Inc.
 $2,192 
 $(12,936)
 $(9,860)
 $(22,665)
Adjustments:
    
    
    
    
Interest expense
  6,188 
  5,694 
  13,064 
  11,075 
Loss contingency on litigation
  -- 
  6,200 
  -- 
  6,200 
Depreciation expense
  1,172 
  1,096 
  2,262 
  2,234 
Accretion of Series A preferred units
  1,362 
  471 
  2,322 
  920 
Share-based compensation
  325 
  196 
  635 
  486 
Intangibles and other amortization expense
  12 
  12 
  24 
  24 
Income tax expense (benefit)
  (56)
  -- 
  (263)
  7 
Total adjustments
  9,003 
  13,669 
  18,044 
  20,946 
Adjusted EBITDA
 $11,195 
 $733 
 $8,184 
 $(1,719)
 
PRODUCTION AND PRICE PERFORMANCE
(unaudited)
 
 
 
Three months ended June 30,
 
 
      Six months ended June 30,
 
 
 
2020
 
 
2019
 
 
2020
 
 
2019  
 
Ethanol
 
 
 
 
 
 
 
 
 
 
 
 
Gallons sold (in millions)
  13.8 
  16.2 
  29.6 
  32.4 
Average sales price/gallon
 $2.63 
 $1.84 
 $2.08 
 $1.76 
Percentage of nameplate capacity
  100%
  118%
  108%
  118%
WDG
    
    
    
    
Tons sold (in thousands)
  90.9 
  106.9 
  198.0 
  213.8 
Average sales price/ton
 $82 
 $81 
 $80 
 $81 
Delivered cost of corn
    
    
    
    
Bushels ground (in millions)
  4.9 
  5.7 
  10.6 
  11.3 
Average delivered cost / bushel
 $4.46 
 $5.37 
 $4.84 
 $5.29 
Biodiesel
    
    
    
    
Metric tons sold (in thousands)
  2.6 
  13.0 
  6.3 
  18.2 
Average sales price/metric ton
 $835 
 $833 
 $786 
 $830 
Percentage of nameplate capacity
  7%
  35%
  8%
  24%
Refined glycerin
    
    
    
    
Metric tons sold (in thousands)
  0.4 
  0.6 
  0.6 
  2.0 
Average sales price/metric ton
 $901 
 $560 
 $772 
 $618 
 
 
6

The following information was filed by Aemetis, Inc (AMTX) on Thursday, August 13, 2020 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Aemetis, Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aemetis, Inc.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account